<DOC>
	<DOCNO>NCT02552550</DOCNO>
	<brief_summary>The curative treatment organ preservation advance squamous cell carcinoma oropharynx multimodal . It involve induction chemotherapy depend response radio-chemotherapy surgery . The combination method important functional consequence . The aim prospective pilot study describe swallowing , speech , also patient ' quality life therapeutic management ( exist study measure function treatment ) .</brief_summary>
	<brief_title>Swallowing , Speech Quality Life Patients With Carcinoma Oropharynx</brief_title>
	<detailed_description>This study change patient 's treatment . This evaluation , treatment , ability swallow , speak , normal practice , 3 , 6 12 month treatment .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Oropharyngeal Neoplasms</mesh_term>
	<criteria>Patient stage T3 T4 squamous cell carcinoma oropharynx previously untreated . Performance status 0 1 Tumor histology prove squamous cell carcinoma Visceral metastasis initial assessment Contraindication surgery / chemotherapy : A history cancer ( except basal cell carcinoma skin cervical cancer situ ) 2nd associate cancer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>squamous cell carcinoma oropharynx</keyword>
	<keyword>swallowing , speech</keyword>
	<keyword>quality life</keyword>
</DOC>